trending Market Intelligence /marketintelligence/en/news-insights/trending/N9lms0nZ59bAqr_MEbTIfg2 content esgSubNav
In This List

Ultragenyx appoints independent director

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Ultragenyx appoints independent director

Ultragenyx Pharmaceutical Inc. appointed Deborah Dunsire to the company's board of directors.

Dunsire, currently president and CEO of XTuit Pharmaceuticals Inc., will serve as an independent director on Ultragenyx's board.